159 related articles for article (PubMed ID: 31073307)
21. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract][Full Text] [Related]
22. 5'isomiR-183-5p|+2 elicits tumor suppressor activity in a negative feedback loop with E2F1.
Li X; Michels BE; Tosun OE; Jung J; Kappes J; Ibing S; Nataraj NB; Sahay S; Schneider M; Wörner A; Becki C; Ishaque N; Feuerbach L; Heßling B; Helm D; Will R; Yarden Y; Müller-Decker K; Wiemann S; Körner C
J Exp Clin Cancer Res; 2022 Jun; 41(1):190. PubMed ID: 35655310
[TBL] [Abstract][Full Text] [Related]
23. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer.
Nakamura Y; Tanaka F; Haraguchi N; Mimori K; Matsumoto T; Inoue H; Yanaga K; Mori M
Br J Cancer; 2007 Aug; 97(4):543-9. PubMed ID: 17653072
[TBL] [Abstract][Full Text] [Related]
25. In Silico and In Vivo Evaluation of microRNA-181c-5p's Role in Hepatocellular Carcinoma.
Abd ElAziz ON; Elfiky AM; Yassin MA; Abd El-Hakam FE; Saleh EM; El-Hefnawi M; Mohamed RH
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553610
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding ribonucleic acid zinc finger E-box binding homeobox 1 antisense RNA 1 regulates myocardial fibrosis in diabetes through the Hippo-Yes-associated protein signaling pathway.
Wu J; Lyu R; Chen S; Wang X
J Diabetes Investig; 2023 Aug; 14(8):940-952. PubMed ID: 37309277
[TBL] [Abstract][Full Text] [Related]
27. Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer.
Mani C; Acharya G; Saamarthy K; Ochola D; Mereddy S; Pruitt K; Manne U; Palle K
Breast Cancer Res; 2023 Apr; 25(1):44. PubMed ID: 37081516
[TBL] [Abstract][Full Text] [Related]
28. The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways.
Kong L; Liu P; Zheng M; Wang Z; Gao Y; Liang K; Wang H; Tan X
Onco Targets Ther; 2020; 13():3449-3466. PubMed ID: 32368099
[TBL] [Abstract][Full Text] [Related]
29. Long Noncoding RNA SNHG5 Induces the NF-κB Pathway by Regulating miR-181c-5p/CBX4 Axis to Promote the Progression of Non-Small Cell Lung Cancer.
Kang S; Ou C; Yan A; Zhu K; Xue R; Zhang Y; Lai J
Arch Bronconeumol; 2023 Jan; 59(1):10-18. PubMed ID: 35963709
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressor protein p53-mediated repression of human mitotic centromere-associated kinesin gene expression is exerted via down-regulation of Sp1 level.
Jun DY; Lee JY; Park HS; Lee YH; Kim YH
PLoS One; 2017; 12(12):e0189698. PubMed ID: 29244835
[TBL] [Abstract][Full Text] [Related]
31. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
32. MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
Yao L; Wang L; Li F; Gao X; Wei X; Liu Z
Int J Clin Exp Med; 2015; 8(9):15198-205. PubMed ID: 26629004
[TBL] [Abstract][Full Text] [Related]
33. MiR-181c suppresses triple-negative breast cancer tumorigenesis by targeting MAP4K4.
Xie D; Li S; Wu T; Wang X; Fang L
Pathol Res Pract; 2022 Feb; 230():153763. PubMed ID: 35026645
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
Zhou L; Zhao LC; Jiang N; Wang XL; Zhou XN; Luo XL; Ren J
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):87-94. PubMed ID: 28121351
[TBL] [Abstract][Full Text] [Related]
35. MiR-891a-5p as a prognostic marker and therapeutic target for hormone receptor-positive breast cancer.
Zhang Z; Xu L; He L; Wang J; Shi X; Li Z; Shi S; Hou K; Teng Y; Qu X
J Cancer; 2020; 11(13):3771-3782. PubMed ID: 32328182
[No Abstract] [Full Text] [Related]
36. Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt/β-catenin signaling pathway.
Ruan Z; Lu L; Zhang L; Dong M
Cancer Gene Ther; 2021 Aug; 28(7-8):785-798. PubMed ID: 32632270
[TBL] [Abstract][Full Text] [Related]
37. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
Zhang J; Kong X; Shi Q; Zhao B
Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
[TBL] [Abstract][Full Text] [Related]
39. MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP).
Li N; Cheng C; Wang T
Onco Targets Ther; 2020; 13():4495-4505. PubMed ID: 32547080
[TBL] [Abstract][Full Text] [Related]
40. miR-181c-5p/DERL1 pathway controls breast cancer progression mediated by TRAF6-linked K63 ubiquitination of AKT.
Bai Y; Zhang Z; Bi J; Tang Q; Jiang K; Yao C; Wang W
Cancer Cell Int; 2024 Jun; 24(1):204. PubMed ID: 38858669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
